Nicotinic receptor function in schizophrenia

Schizophrenia Bulletin

Volumn 22, Issue 3, 1996, Pages 431-445

  Leonard, Sherry ^a,b   Adams, Catherine ^c   Breese, Charles R ^c   Adler, Lawrence E ^d   Bickford, Paula ^b   Byerley, William ^e   Coon, Hilary ^e   Griffith, Jay M ^f   Miller, Christine ^c   Myles Worsley, Marina ^e   Nagamoto, Herbert T ^b   Rollins, Yvonne ^d   Stevens, Karen E ^c   Waldo, Merilyne ^d   Freedman, Robert ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Department of Psychiatry ^*  (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^f SOUTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR;

CHANNEL GATING; EVOKED AUDITORY RESPONSE; HUMAN; INFORMATION PROCESSING; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SENSORY DYSFUNCTION;

EID: 0342596099     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.3.431     Document Type: Review

References (101)

1. Adler, L.E.; Gerhardt, G.A.; Franks, R.; Baker, N.; Nagamoto, H.; Drebing, C.; and Freedman, R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Research, 31:297-309, 1990.
2. Adler, L.E.; Hoffer, L.; Griffith, J.M.; Waldo, M.C.; and Freedman, R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biological Psychiatry, 32:607-616, 1992.
3. Adler, L.E.; Hoffer, L.; Nagamoto, H.T.; Waldo, M.C.; Kisley, M.A.; and Griffith, J.M. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology, 10:249-257, 1994.
4. Adler, L.E.; Hoffer, L.; Wiser, A.; and Freedman, R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry, 150:1856-1861, 1993.
5. Adler, L.E.; Pachtman, E.; Franks, R.; Pecevich, M.; Waldo, M.C.; and Freedman, R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry, 17:639-654, 1982.
6. Adler, L.E.; Rose, G.M.; and Freedman, R. Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biological Psychiatry, 21:787-798, 1986.
7. Adler, L.E.; Rose, G.M.; Pang, J.; and Gerhardt, G. Modulation of the gating of auditory evoked potentials by norepinephrine and dopamine: Pharmacological evidence obtained using a selective neurotoxin. Biological Psychiatry, 24:179-190, 1988.
8. Alonso, A., and Kohler, C. Evidence for separate projections of hippocampal and non-pyramidal neurons to different parts of the septum in rat brain. Neuroscience Letters, 21:209-214, 1982.
9. Andreasen, N.C. Positive vs. negative schizophrenia: A critical evaluation. Schizophrenia Bulletin, 11(3):380-389, 1985.
10. Berger, P.A.; Davis, K.L.; and Hollister, L.E. Pharmacological investigations of cholinergic mechanisms of psychosis in schizophrenia and manic psychosis. In: Davis, K.L., and Berger, P.A., eds. Brain Acetylcholine and Neuropsychiatric Disease. New York, NY: Plenum Press, 1979. pp. 15-32.
11. Bickford, P.C.; Luntz-Leybman, V.; and Freedman, R. Auditory sensory gating in the rat hippocampus: Modulation by brainstem activity. Brain Research, 607:33-38, 1993.
12. Bickford, P.C., and Wear, K. Fimbria fornix lesions disrupt auditory sensory gating in the rat hippocampus. Brain Research, 705:235-240, 1995.
13. Bickford-Wimer, P.C.; Nagamoto, H.; Johnson, R.; Adler, L.; Egan, M.; Rose, G.M.; and Freedman, R. Auditory sensory gating in hippocampal neurons: A model system in the rat. Biological Psychiatry, 27:183-192, 1990.
14. Blackwood, D.H.; St. Clair, D.M.; Muir, W.J.; and Duffy, J.C. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Archives of General Psychiatry, 48:899-909, 1991.
15. Boutros, N.N.; Overall, J.; and Zouridakis, G. Test-retest reliability of the P50 mid-latency auditory evoked response. Psychiatry Research, 39:181-192, 1991.
16. Braff, D.L.; Grillon, C.; and Geyer, M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry, 49:206-215, 1992.
17. Braff, D.L., and Saccuzzo, D.P. The time course of information-processing deficits in schizophrenia. American Journal of Psychiatry, 142:170-174, 1985.
18. Catalano, M.; Nobile, M.; Novelli, E.; and Smeraldi, E. Use of polymerase chain reaction DNA denaturing gradient gel electrophoresis to identify polymorphisms in three exons of dopamine D2 receptor gene in schizophrenic and delusional patients. Biological Psychiatry, 26:1-3, 1992.
19. Chen, S., and Bentivoglio, M. Nerve growth factor receptor-containing cholinergic neurons of the basal forebrain project to the thalamic reticular nucleus in the rat. Brain Research, 606:207-212, 1993.
20. Chiappinelli, V. Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors. Pharmacology and Therapeutics, 31:1-32, 1985.
21. Chini, B.; Raimond, E.; Elgoyhen, A.B.; Moralli, D.; Balzaretti, M.; and Heinemann, S. Molecular cloning and chromosomal localization of the human 7-nicotinic receptor subunit gene (CHRNA7). Genomics, 19:379-381, 1994.
22. Clarke, D.J. Prader-Willi syndrome and psychoses. British Journal of Psychiatry, 163:680-684, 1993.
23. 125I]-α-bungarotoxin. Journal of Neuroscience, 5:1307-1315, 1985.
24. Cloninger, C.R. Turning point in the design of linkage studies of schizophrenia. America Journal of Medical Genetics: Neuropsychiatric Genetics, 54:83-92, 1994.
25. Coon, H.; Plaetke, R.; Holik, J.; Hoff, M.; Myles-Worsley, M.; Waldo, M.; Freedman, R.; and Byerley, W. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biological Psychiatry, 34:277-289, 1993.
26. Crick, F. Function of the thalamic reticular complex: The searchlight hypothesis. Proceedings of the National Academy of Sciences of the United States of America, 81:4586-4590, 1984.
27. Crowley, C.; Spencer, S.D.; Nishimura, M.C.; Chem, K.S.; Pitts-Meek, S.; Armanini, M.P.; Ling, L.H.; McMahon, S.B.; Shelton, D.L.; Levinson, A.D.; and Phillips, H.S. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell, 76:1001-1011, 1994.
28. Davis, H.; Mast, T.; Yoshie, N.; and Zerlin, S. The slow response of the human cortex to auditory stimuli: Recovery cycle process. Electroencephalography and Clinical Neurophysiology, 21:105-113, 1966.
29. De Amicis, L.E.; Wagstaff, D.A.; and Cromwell, R.L. Reaction time crossover as a marker of schizophrenia and of higher functioning. Journal of Nervous and Mental Disease, 174:177-179, 1986.
30. Deneris, E.S.; Connolly, J.; Rogers, S.W.; and Duvoisin, R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends in Pharmacological Sciences, 12:34-40, 1991.
31. B receptors in the hippocampus have different pharmacological properties. Neuron, 1:585-591, 1988.
32. Eccles, J.C. The Inhibitory Pathways of the Central Nervous System. Springfield, IL: Charles C Thomas, 1969.
33. Elgoyhen, A.B.; Johnson, D.S.; Boulter, J.; Vetter, D.E.; and Heinemann, S. Alpha 9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell, 79:705-715, 1994.
34. Foster, T.C., and Deadwyler, S.A. Acetylcholine modulates averaged sensory evoked response and perforant path evoked field potentials in the rat dentate gyrus. Brain Research, 587:95-101, 1992.
35. Freedman R.; Adler, L.E.; Baker, N.; Waldo, M.; and Mizner, G. Candidate for inherited neurobiological dysfunction in schizophrenia. Somatic Cell and Molecular Genetics, 13:479-484, 1987.
36. Freedman, R.; Adler, L.E.; Waldo, M.C.; Pachtman, E.; and Franks, R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biological Psychiatry, 18:537-551, 1983.
37. Freedman, R.; Hall, M.; Adler, L.E.; and Leonard, S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biological Psychiatry, 38:22-33, 1995.
38. Freedman, R.; Waldo, M.; Bickford-Wimer, P.; and Nagamoto, H. Elementary neuronal dysfunctions in schizophrenia. Schizophrenia Research, 4:233-243, 1991.
39. Freedman, R.; Wetmore, C.; Strömberg, I.; Leonard, S.; and Olson, L. α-Bungarotoxin binding to hippocampal interneurons: Immunocytochemical characterization and effects on growth factor expression. Journal of Neuroscience, 13:1965-1975, 1993.
40. Freund, R.F. GABAergic septal and serotonergic median raphe afferents preferentially innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Research, 7(Suppl.):79-91, 1992.
41. Goff, D.C.; Henderson, D.C.; and Amico, E. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry, 149:1189-1194, 1992.
42. Goff, W.R.; Williamson, P.D.; VanGilder, J.C.; Allison, R.; and Fisher, T.C. Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man. Progress in Clinical Neurophysiology, 7:126-145, 1980.
43. Gottesman, I.I., and Shields, J. Schizophrenia: The Epigenetic Puzzle. Cambridge, England: Cambridge University Press, 1982.
44. Greeman, M., and McClellan, T.A. Negative effects of a smoking ban on an inpatient psychiatry service. Hospital and Community Psychiatry, 42:408-412, 1991.
45. Guterman, Y.; Josiassen, R.C.; and Bashore, T.R., Jr. Attentional influence on the P50 component of the auditory event-related brain potential. International Journal of Psychophysiology, 12:197-209, 1992.
46. B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neuroscience Letters, 190:133-136, 1995.
47. Holzman, P.S.; Kringlen, E.; Matthysse, S.; Flanagan, S.D.; Lipton, R.B.; Cramer, G.; Levin, S.; Lange, K.; and Levy, D.L. A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Archives of General Psychiatry, 45:641-647, 1988.
48. Hughes, J.R.; Hatsukami, D.K.; Mitchell, J.E.; and Dahlgren, I.A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143:993-997, 1986.
49. Isaacson, J.S.; Solis, J.M.; and Nicoll, R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron, 10:165-175, 1993.
50. Jerger, K.; Biggins, C.; and Fein, G. P50 suppression is not affected by attentional manipulations. Biological Psychiatry, 31:365-377, 1992.
51. Jeste, D.V., and Lohr, J.B. Hippocampal pathologic findings in schizophrenia. Archives of General Psychiatry, 46:1019-1024, 1989.
52. Johnson, M.R., and Adler, L.E. Transient impairment in P50 auditory sensory gating induced by a cold pressor test. Biological Psychiatry, 33:380-387, 1993.
53. Johnson, S.W.; Palmer, M.R.; and Freedman, R. Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology, 22:843-851, 1983.
54. Judd, L.L.; McAdams, L.; Budnick, B.; and Braff, D.L. Sensory gating deficits in schizophrenia: New results. American Journal of Psychiatry, 149:488-493, 1992.
55. Karson, C.N,; Casanova, M.F.; Kleinman, J.E.; and Griffin, W.S. Choline acetyltransferase in schizophrenia. American Journal of Psychiatry, 150:454-459, 1993.
56. Kirch, D.G.; Bigelow, L.B.; Weinberger, D.R.; Lawson, W.B.; and Wyatt, R.J. Polydipsia and chronic hyponatremia in schizophrenic inpatients. Journal of Clinical Psychiatry, 46:179-181, 1985.
57. Knusel, B.; Michel, P.P.; Schwaber, J.S.; and Hefti, F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. Journal of Neuroscience, 10:558-570, 1990.
58. Lozsádi, D. A. Organization of cortical afferents to the rostral, limbic sector of the rat thalamic reticular nucleus. Journal of Comparative Neurology, 341:520-533, 1994.
59. Lukas, R.J., and Bencherif, M. Heterogeneity and regulation of nicotinic acetylcholine receptors. International Review of Neurobiology, 34:25-131, 1992.
60. Luntz-Leybman, V.; Bickford, P.C.; and Freedman, R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Research, 587:130-136, 1992.
61. Madison, D.V., and Nicoll, R.A. Norepinephrine decreases synaptic inhibition in the rat hippocampus. Brain Research, 442:131-138, 1988.
62. Manzone, O.J.; Manabe, T.; and Nicoll, R. Release of adenosine by activation of NMDA receptors in the hippocampus. Science, 265:2098-2101, 1994.
63. McCarley, R.W.; Shenton, M.E.; O'Donnell, B.F.; and Nestor, P.G. Uniting Kraepelin and Bleuler: The psychology of schizophrenia and the biology of temporal lobe abnormalities. Harvard Review of Psychiatry, 1:36-52, 1993.
64. McDonald, J.W., and Johnstone, M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Research Reviews, 15:41-70, 1990.
65. McGlashan, T.H., and Fenton, W.S. The positive-negative distinction in schizophrenia: Review of natural history validators. Archives of General Psychiatry, 49:63-72, 1992.
66. McGue, M., and Gottesman, I.I. Genetic linkage in schizophrenia: Perspectives from genetic epidemiology. Schizophrenia Bulletin, 15(3):453-464, 1989.
67. Meehl, P.E. Schizotaxia, schizotypy, schizophrenia. American Psychologist, 17:827-838, 1962.
68. Menza, M.A.; Grossman, N.; Van Horn, C.; Cody, R.; and Forman, N. Smoking and movement disorders in psychiatric patients. Biological Psychiatry, 30:109-115, 1991.
69. Metherate, R., and Ashe, J.H. Nucleus basalis stimulation facilitates thalamocortical synaptic transmission in the rat auditory cortex. Synapse, 14:132-143, 1993.
70. Miller, C., and Freedman, R. Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience, 55:373-380, 1993.
71. Miller, C., and Freedman, R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience, 69:371-381, 1995.
72. Mitrofanis, J., and Guillery, R.W. New views of the thalamic reticular nucleus in the adult and the developing brain. Trends in Neurosciences, 16:240-245, 1993.
73. Nagamoto, H.T.; Adler, L.E.; Hea, R.A.; Griffith, J.M.; McRae, K.A.; and Freedman, R. Gating of auditory P50 in schizophrenics: Unique effects of clozapine. Biological Psychiatry, in press.
74. Pfeiffer, C.C., and Jenny, E.H. The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain. Annals of the New York Academy of Sciences, 66:753-764, 1957.
75. Reite, M.; Teals, P.; Zimmerman, J.E.; Davis, K.; Whalen, J.; and Edrich, J. Source origin of a 50-msec latency auditory evoked field component in young schizophrenic men. Biological Psychiatry, 24:495-506, 1988.
76. Rollins, Y.D.; Stevens, K.E.; Harris, K.R.; Hall, M.E.; Rose, G.M.; and Leonard, S. Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α7 antisense oligonucleotides. Society of Neuroscience Abstracts, 19:837, 1993.
77. Rosenthal, R., and Bigelow, L.G. The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: Preliminary observations. Comprehensive Psychiatry, 14:489-494, 1973.
78. Sarkar, G.; Kapelner, S.; Grandy, D.K.; Marchionni, M.; Civelli, O.; Sobell, J.; Heston, L.; and Sommer, S.S. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics, 11:8-14, 1991.
79. Schoepfer, R.; Conroy, W.G.; Whiting, P.; Gore, M.; and Lindstrom, J. Brainbungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron, 5:35-48, 1990.
80. Schotte, A.; Janssen, P.F.; Megens, A.A.; and Leysen, J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine, and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research, 631:191-202, 1993.
81. Séguéla, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J.A.; and Patrick, J.W. Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium. Journal of Neuroscience, 13:596-604, 1993.
82. Siegel, C.; Waldo, M.; Mizner, G.; Adler, L.E.; and Freedman, R. Deficits in sensory gating in schizophrenic patients and their relatives. Archives of General Psychiatry, 41:607-612, 1984.
83. Simpson, G.V., and Knight, R.T. Multiple brain systems generating the rat auditory evoked potential: II. Dissociation of auditory cortex and nonlemniscal generator systems. Brain Research, 602:251-263, 1993.
84. Sirota, P.; Frydman, M.; and Sirota, L. Schizophrenia and Marfan syndrome. British Journal of Psychiatry, 157:433-436, 1990.
85. Snider, W.D., and Johnson, E.M., Jr. Neurotrophic molecules. Annals of Neurology, 26:489-506, 1989.
86. Stafekhina, V.S., and Vinogradova, O.S. Sensory characteristics of the cortical input to the hippocampus: The entorhinal cortex. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I. P. Pavlova, 25:119-127, 1975.
87. Stevens, D.R., Birnstiel, S.; Gerber, U.; McCarley, R.W.; and Greene, R.W. Nicotine depolarizations of rat medial pontine reticular formation neurons studied in vitro. Neuroscience, 57:419-424, 1993.
88. Stevens, K.E.; Freedman, R.; Collins, A.C.; Hall, M.; Leonard, S.; Marks, M.J.; and Rose, G.M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and α-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology, in press.
89. Stevens, K.E.; Meltzer, J.; and Rose, G.M. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely-moving rats. Psychopharmacology, 119:163-170, 1995.
90. Straumanis, J.J.; Shagass, C.; and Roemer, R.A. Influence of antipsychotic and antidepressant drugs on evoked potential correlates of psychosis. Biological Psychiatry, 17:1101-1122, 1982.
91. Suddath, R.L.; Christison, G.W.; Torrey, E.F.; Casanova, M.F.; and Weinberger, D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322:789-794, 1990.
92. Swerdlow, N.R.; Braff, D.L.; Taaid, N.; and Geyer, M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry, 51:139-154, 1994.
93. Tandon, R., and Greden, J.F. Cholinergic hyperactivity and negative schizophrenic symptoms. Archives of General Psychiatry, 46:745-753, 1989.
94. Tsuang, M.T. Genotypes, phenotypes, and the brain: A search for connections in schizophrenia. British Journal of Psychiatry, 163:299-307, 1993.
95. Venables, P. Input dysfunction in schizophrenia. In: Maher, B.A., ed. Progress in Experimental Personality Research. New York, NY: Academic Press, 1964. pp. 1-47.
96. Vinogradova, O. Functional organization of the limbic system in the process of registration of information. In: Issacson, R.L., and Pribram, K.H., eds. The Hippocampus: Neurophysiology and Behavior. Vol. 1. New York, NY: Plenum Press, 1975. pp. 3-69.
97. Waldo, M.C.; Carey, G.; Myles-Worsley, M.; Cawthra, E.; Adler, L.E.; Nagamoto, H.T.; Wender, P.; Byerley, W.; Plaetke, R.; and Freedman, R. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Research, 39:257-268, 1991.
98. Waldo, M.C.; Cawthra, E.; Adler, L.E.; Dubester, S.; Staunton, M.; Nagamoto, H.T.; Baker, N.; Madison, A.; Simon, J.; Scherzinger, A.; Drebing, C.; Gerhardt, G.; and Freedman, R. Auditory sensory gating, hippocampal volume, and catecholamine metabolism and schizophrenics and their siblings. Schizophrenia Research, 12:93-106, 1994.
99. Waldo, M.; Gerhardt, G.; Baker, N.; Drebing, C.; Adler, L.E.; and Freedman, R. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects. Psychiatry Research, 44:21-32, 1992.
100. Wilson, C.L.; Babb, T.L.; Halgren, E.; Wang, M.L.; and Crandall, P.H. Habituation of human limbic neuronal response to sensory stimulation. Experimental Neurology, 84:74-97, 1984.
101. Wonnacott, S. α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. Journal of Neurochemistry, 47:1706-1712, 1986.